Sumitomo Pharma Co., Ltd. (DNPUF)
OTCMKTS · Delayed Price · Currency is USD
7.24
+0.90 (14.20%)
At close: Jul 17, 2025
Alteryx Market Cap
Sumitomo Pharma has a market cap or net worth of $3.64 billion as of August 8, 2025. Its market cap has increased by 250.93% in one year.
Market Cap
3.64B
Enterprise Value
5.60B
Revenue
2.88B
Ranking
n/a
PE Ratio
27.77
Stock Price
$7.24
Market Cap Chart
Since January 14, 1992, Sumitomo Pharma's market cap has increased from 1.62B to 3.64B, an increase of 124.02%. That is a compound annual growth rate of 2.43%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Aug 7, 2025 | 3.61B | 153.76% |
| Dec 30, 2024 | 1.42B | 8.36% |
| Dec 29, 2023 | 1.31B | -56.36% |
| Dec 30, 2022 | 3.01B | -34.17% |
| Dec 30, 2021 | 4.57B | -21.94% |
| Dec 30, 2020 | 5.86B | -24.66% |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Nika Pharmaceuticals | 972.93M |
| Veradigm | 806.69M |
| Tian'an Technology Group | 628.15M |
| Elite Pharmaceuticals | 604.98M |
| Glass House Brands | 474.59M |
| Northwest Biotherapeutics | 368.08M |
| American Oncology Network | 330.70M |
| CytoDyn | 328.51M |